Rasmussen's encephalitis is a rare and progressive neurological disorder that primarily affects children. It is characterized by inflammation and damage to one hemisphere of the brain, leading to seizures, cognitive decline, and motor deficits. While there is no known cure for Rasmussen's encephalitis, several treatment options can help manage symptoms and improve the quality of life for affected individuals.
Antiepileptic medications are commonly prescribed to control seizures associated with Rasmussen's encephalitis. These medications work by stabilizing the electrical activity in the brain and reducing the frequency and severity of seizures. The choice of medication depends on the individual's specific needs and may involve a trial-and-error process to find the most effective drug and dosage.
Immunomodulatory therapies aim to suppress the immune system's abnormal response, which is believed to contribute to the progression of Rasmussen's encephalitis. These treatments can help reduce inflammation and slow down the damage to the affected hemisphere. Commonly used immunomodulatory therapies include:
In severe cases of Rasmussen's encephalitis that do not respond to medications or immunomodulatory therapies, epilepsy surgery may be considered. The most common surgical procedure for this condition is a hemispherectomy, where the affected hemisphere of the brain is either partially or completely removed. This surgery can help control seizures and prevent further damage to the unaffected hemisphere.
Alongside medical interventions, various supportive therapies can significantly improve the quality of life for individuals with Rasmussen's encephalitis. These may include:
It is important to note that the effectiveness of treatments may vary among individuals, and a multidisciplinary approach involving neurologists, neurosurgeons, immunologists, and rehabilitation specialists is crucial for optimal management of Rasmussen's encephalitis.